Table 2 Lectins showing a significant difference between CCA and PDAC by univariate analysis

From: Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1

Lectins

P-valuea

Positive rate (%)b

AUC

  

CCA

PDAC

 

Seven lectins with significant increases in CCA patients

 PWM

<0.0001

16/21 (76.2%)

5/52 (9.6%)

0.8388

 BPL

0.0004

20/21 (95.2%)

25/52 (48.1%)

0.7573

 PHA-E

0.002

14/21 (66.7%)

16/52 (30.8%)

0.723

 DSA

0.0019

15/21 (71.4%)

19/52 (36.5%)

0.7202

 ECA

0.007

16/21 (76.2%)

16/52 (30.8%)

0.685

 STL

0.0154

15/21 (71.4%)

16/52 (30.8%)

0.6786

 UDA

0.0278

13/21 (61.9%)

13/52 (25.0%)

0.674

Two lectins with significant increases in PDAC patients

 MAL

< 0.0001

3/21 (14.3%)

38/52 (73.1%)

0.8146

 AOL

0.0333

6/21 (28.6%)

30/52 (57.7%)

0.6662

  1. Abbreviations: AUC, area under the receiver operating characteristic curves; CCA, cholangiocarcinoma; PDAC, pancreatic ductal adenocarcinoma.
  2. aP-values were calculated by Mann–Whitney U-test.
  3. bPositive rate was calculated from the cutoff values.
Back to article page